Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

Shareholder Update Call

27 Mar 2025 07:00

RNS Number : 4161C
Alpha Growth PLC
27 March 2025
 

 

 

REACH: non-regulatory announcement

Alpha Growth plc

("Alpha" or the "Company")

Shareholder Update Call

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services company in the life insurance linked asset/wealth management business, announces that their leadership team will host a live interactive call on the Engage Investor platform, on the 2nd of April 2025, at 11:00am BST. 

Alpha Growth Plc welcomes all current shareholders to join and encourages shareholders to pre-submit questions. Investors can also submit questions at any time during the live presentation. 

Investors can sign up to Engage Investor at no cost and follow Alpha Growth Plc from their personalised investor hub.

Register interest in this event here: https://engageinvestor.news/alpha_IP25

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

Allenby Capital Limited

+44 (0) 20 3328 5656

Amrit Nahal (Sales and Corporate Broking)

Nick Athanas / Piers Shimwell (Corporate Finance)

 

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

 

About Alpha Growth plc

 

Specialist in Longevity Assets

 

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management. Building on its well-established network, the Alpha Growth group has a unique position in the insurance and asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

 

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

***END***

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAEDXAEASEEA
Date   Source Headline
13th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20214:42 pmRNSSecond Price Monitoring Extn
5th May 20214:36 pmRNSPrice Monitoring Extension
27th Apr 20214:41 pmRNSSecond Price Monitoring Extn
27th Apr 20214:35 pmRNSPrice Monitoring Extension
27th Apr 20212:05 pmRNSSecond Price Monitoring Extn
27th Apr 20212:00 pmRNSPrice Monitoring Extension
23rd Apr 20214:41 pmRNSSecond Price Monitoring Extn
23rd Apr 20214:35 pmRNSPrice Monitoring Extension
20th Apr 20214:40 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
9th Apr 20219:05 amRNSSecond Price Monitoring Extn
9th Apr 20219:00 amRNSPrice Monitoring Extension
9th Apr 20217:00 amRNSTrading Update Q1 2021
23rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Mar 20212:06 pmRNSSecond Price Monitoring Extn
23rd Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Mar 202111:05 amRNSSecond Price Monitoring Extn
23rd Mar 202111:00 amRNSPrice Monitoring Extension
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSCompletion of Share Purchase Acquisition
17th Mar 20214:41 pmRNSSecond Price Monitoring Extn
17th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSHolding(s) in Company
16th Mar 20217:00 amRNSHolding(s) in Company
8th Mar 20217:00 amRNSIssue of Placing Shares
5th Mar 202112:00 pmRNSResults of the Annual General Meeting
11th Feb 20214:41 pmRNSSecond Price Monitoring Extn
11th Feb 20214:35 pmRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:00 pmRNSPrice Monitoring Extension
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSStrategic Acquisition and Company Update
5th Feb 20214:42 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
5th Feb 20212:06 pmRNSSecond Price Monitoring Extn
5th Feb 20212:01 pmRNSPrice Monitoring Extension
20th Jan 20216:27 pmRNSHolding(s) in Company
15th Jan 20219:05 amRNSSecond Price Monitoring Extn
15th Jan 20219:00 amRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSBlackOak Alpha Growth Fund Year End Results
7th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20217:00 amRNSFurther re 2020 Annual Report
31st Dec 202011:05 amRNSSecond Price Monitoring Extn
31st Dec 202011:00 amRNSPrice Monitoring Extension
31st Dec 20209:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.